← Back to Search

Behavioral Intervention

Experimental for Depression

N/A
Waitlist Available
Led By Nicholas C Jacobson, PhD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up each participant in the depression cohort will fill out a questionnaire to establish baseline symptoms, and they will fill out this questionnaire again after 4 and 8 weeks of using the therapy chatbot to track changes in their symptoms.
Awards & highlights

Study Summary

This trial will test if a chatbot using artificial intelligence can effectively provide support for people with anxiety, depression, or eating issues.

Who is the study for?
This trial is for people who experience anxiety, depression, or eating disorders as confirmed by specific questionnaires (PHQ-9 for depression, GADQ-IV for anxiety, and SWED 3.0 for eating concerns). Participants will be recruited online through various platforms like Facebook and Reddit.Check my eligibility
What is being tested?
The study is examining the effectiveness of 'Therabot', an AI chatbot designed to provide supportive behavioral interventions to individuals with mental health conditions such as anxiety, depression, or disordered eating.See study design
What are the potential side effects?
Since this intervention involves a chatbot providing psychological support rather than medication or medical procedures, traditional physical side effects are not expected. However, users may experience emotional discomfort or distress during interactions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~each participant in the depression cohort will fill out a questionnaire to establish baseline symptoms, and they will fill out this questionnaire again after 4 and 8 weeks of using the therapy chatbot to track changes in their symptoms.
This trial's timeline: 3 weeks for screening, Varies for treatment, and each participant in the depression cohort will fill out a questionnaire to establish baseline symptoms, and they will fill out this questionnaire again after 4 and 8 weeks of using the therapy chatbot to track changes in their symptoms. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety Symptoms
Depressive Symptoms
Eating Disorders Symptoms

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
This group will have access to the Therabot smartphone application. They will interact with the generative chatbot daily to discuss their mental health. Each participant in this group will have some benchmark symptoms of depression, anxiety, or eating disorders. They will fill out questionnaires every 4 weeks to describe changes in symptoms.
Group II: ControlActive Control1 Intervention
This group will not have access to the Therabot App. They will fill out questionnaires every 4 weeks to describe changes in symptoms. Each participant in this group will have some benchmark symptoms of depression, anxiety, or eating disorders.

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor
526 Previous Clinical Trials
2,541,052 Total Patients Enrolled
23 Trials studying Depression
4,232 Patients Enrolled for Depression
Nicholas C Jacobson, PhDPrincipal InvestigatorDartmouth-Hitchcock Medical Center
1 Previous Clinical Trials
63 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants currently being enrolled in this trial?

"According to clinicaltrials.gov, this particular research study is not currently seeking participants. It was initially listed on 3/11/2024 and last modified on 4/15/2024. Although recruitment for this trial has ceased, there are a total of 1782 other trials actively enrolling subjects at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Chatbot for Depression, Anxiety, and Eating Disorders
Nicholas C. Jacobson 2024. "Chatbot for Depression, Anxiety, and Eating Disorders". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06013137.
All > Eating Disorder
~140 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top